Institutional Ownership Alnylam Pharmaceuticals, Inc. (ALNY)
This table provides information about the institutional ownership of Alnylam Pharmaceuticals, Inc. (ALNY). We have compiled data on the 675 institutions that hold shares in the stock, with a total of 108 Million shares, which have been reported (via 13F filing form) to have a value of $25.4 Billion.
Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
---|---|---|---|---|---|
Deutsche Bank Ag\
Frankfurt Am Main, 2M |
Feb 14, 2025 Q4 2024 |
556,579
shares
|
$131 Million
0.05% of portfolio
|
Q4 2024
Added 3.21%
|
|
Charles Schwab Investment Management Inc
San Francisco, CA |
Feb 06, 2025 Q4 2024 |
513,962
shares
|
$121 Million
0.02% of portfolio
|
Q4 2024
Added 5.46%
|
|
Td Asset Management Inc
|
Feb 11, 2025 Q4 2024 |
504,038
shares
|
$118 Million
0.11% of portfolio
|
Q4 2024
Added 3.23%
|
|
Loomis Sayles & CO L P
|
Feb 12, 2025 Q4 2024 |
503,045
shares
|
$118 Million
0.15% of portfolio
|
Q4 2024
Reduced 4.24%
|
|
Amundi
Paris, I0 |
Feb 07, 2025 Q4 2024 |
496,301
shares
|
$116 Million
0.04% of portfolio
|
Q4 2024
Reduced 16.35%
|
|
Qube Research & Technologies LTD
London, X0 |
Feb 14, 2025 Q4 2024 |
485,260
shares
|
$114 Million
0.16% of portfolio
|
Q4 2024
Added 218.91%
|
|
Nuveen Asset Management, LLC
Chicago, IL |
Feb 14, 2025 Q4 2024 |
448,881
shares
|
$105 Million
0.03% of portfolio
|
Q4 2024
Added 1.77%
|
|
Pictet Asset Management Holding Sa
Carouge, V8 |
Feb 12, 2025 Q4 2024 |
430,612
shares
|
$101 Million
0.11% of portfolio
|
Q4 2024
Reduced 35.22%
|
|
Bank Of America Corp
Charlotte, NC |
Feb 14, 2025 Q4 2024 |
418,552
shares
|
$98.2 Million
0.01% of portfolio
|
Q4 2024
Reduced 24.01%
|
|
Orbimed Advisors LLC
San Diego, CA |
Feb 14, 2025 Q4 2024 |
415,600
shares
|
$97.5 Million
2.65% of portfolio
|
Q4 2024
Added 66.04%
|
|
Franklin Resources Inc
San Mateo, CA |
Feb 12, 2025 Q4 2024 |
414,139
shares
|
$97.1 Million
0.03% of portfolio
|
Q4 2024
Added 8.14%
|
|
Marshall Wace, LLP
London, X0 |
Feb 13, 2025 Q4 2024 |
378,649
shares
|
$88.8 Million
0.11% of portfolio
|
Q4 2024
Added 496.61%
|
|
Gilder Gagnon Howe & CO LLC
New York, NY |
Feb 14, 2025 Q4 2024 |
365,463
shares
|
$85.7 Million
1.0% of portfolio
|
Q4 2024
Reduced 4.83%
|
|
D. E. Shaw & Co., Inc.
New York, NY |
Feb 14, 2025 Q4 2024 |
363,085
shares
|
$85.2 Million
0.07% of portfolio
|
Q4 2024
Added 9.26%
|
|
Swiss National Bank
Zurich, V8 |
Feb 10, 2025 Q4 2024 |
362,600
shares
|
$85.1 Million
0.06% of portfolio
|
Q4 2024
Reduced 3.41%
|
|
Dimensional Fund Advisors LP
Austin, TX |
Feb 13, 2025 Q4 2024 |
333,661
shares
|
$78.3 Million
0.02% of portfolio
|
Q4 2024
Added 10.71%
|
|
Israel Englander
Millennium Management LLC | New York, Ny
|
Feb 14, 2025 Q4 2024 |
333,442
shares
|
$78.2 Million
0.04% of portfolio
|
Q4 2024
Added 32.87%
|
|
First Trust Advisors LP
Wheaton, IL |
Feb 13, 2025 Q4 2024 |
327,782
shares
|
$76.9 Million
0.07% of portfolio
|
Q4 2024
Added 14.78%
|
|
Royal Bank Of Canada
Toronto, A6 |
Feb 14, 2025 Q4 2024 |
310,187
shares
|
$72.8 Million
0.02% of portfolio
|
Q4 2024
Reduced 24.54%
|
|
Polar Capital Holdings PLC
London, X0 |
Feb 14, 2025 Q4 2024 |
310,000
shares
|
$72.7 Million
0.45% of portfolio
|
Q3 2024
Added 8.77%
|
|
Eagle Asset Management Inc
St Petersburg, FL |
Nov 12, 2024 Q3 2024 |
309,589
shares
|
$72.6 Million
0.51% of portfolio
|
Q3 2024
Added 25.74%
|
|
Eaton Vance Management
Boston, MA |
Nov 14, 2022 Q3 2022 |
307,288
shares
|
$72.1 Million
0.09% of portfolio
|
Q3 2022
Added 0.18%
|
|
Goldman Sachs Group Inc
New York, NY |
Feb 11, 2025 Q4 2024 |
306,455
shares
|
$71.9 Million
0.01% of portfolio
|
Q4 2024
Reduced 13.94%
|
|
Ubs Group Ag
|
Feb 14, 2025 Q4 2024 |
289,966
shares
|
$68 Million
0.01% of portfolio
|
Q4 2024
Added 86.27%
|
|
Sumitomo Mitsui Trust Holdings, Inc.
|
Jan 28, 2025 Q4 2024 |
286,703
shares
|
$67.2 Million
0.05% of portfolio
|
Q4 2024
Added 3.04%
|